secwatch.observer — SEC 8-K summary
======================================

Issuer:     Parabilis Medicines, Inc. (PBLS)
CIK:        0001657677
Form:       8-K
Filed at:   2026-09-15T20:15:35+00:00
Accession:  0001193125-26-391952
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Parabilis to present updated zolucatetide data in desmoid tumors at ESMO 2026
-----------------------------------------------------------------------------

- Updated Phase 1/2 zolucatetide data in desmoid tumors to be presented at ESMO Congress 2026 in Madrid.
- Oral presentation scheduled Oct 24, 2:45pm CEST in sarcoma-focused Proffered Paper session.
- Company updates guidance to reflect intention to present data; no numbers disclosed yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1657677/000119312526391952/0001193125-26-391952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1657677/000119312526391952/ck0001657677-20260915.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-391952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer